Serum Biomarkers for Early Prediction of Outcome After Moderate-to-Severe Traumatic Brain Injury
DEVELOPMENTAL MEDICO-LIFE-SCIENCES · 30.06.2026 · 3 (6) · 24-31
DOI: 10.69750/dmls.03.06.0216 ↗Kurz gefasst
Fachartikel in der Zeitschrift DEVELOPMENTAL MEDICO-LIFE-SCIENCES, online erschienen am 30.06.2026. Verfasst von Rimmal Rahim und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The prognosis following moderate-to-severe traumatic brain injury (TBI) is difficult to predict accurately in the early stage.
Objective
To evaluate the prognostic value of early serum biomarkers in predicting six-month functional outcomes among patients with moderate-to-severe traumatic brain injury.
Methods
This prospective observational study was conducted in the Department of Neurosurgery and Neurocritical Care, Nishtar Hospital, Nishtar Medical University, Multan, Pakistan, from March 2023 to March 2025.Serial GFAP, UCH-L1, NSE, and S100B levels were obtained within 6 hours of admission. At six months, functional outcome was evaluated using the Glasgow Outcome Scale-Extended and divided into favourable and unfavourable outcomes.
Results
A favourable outcome was observed in 72 patients, while 48 had an unfavourable outcome, including 20 deaths. The GFAP, UCH-L1, NSE, and S100B levels were significantly higher for patients with an unfavourable outcome compared to patients with a favourable recovery. GFAP was the best predictor of unfavourable outcome with an AUC of 0.86, followed by UCH-L1 (AUC 0.81). The combined GFAP and UCH-L1 model had better predictive accuracy (AUC 0.89). Multivariable analysis revealed GFAP, UCH-L1, a lower GCS on admission, non-reactive pupils, a higher Marshall CT grade, and higher age to be independent predictors of poor outcome.
Conclusions
The serum assessment of these biomarkers is a valuable prognostic tool following moderate to severe TBI. GFAP and UCH-L1 seem to be the most promising early markers and could potentially be used to help stratify patients clinically.
Zitieren
APA
Rahim, R., Mushtaq, U., & Abbas, E. (2026). Serum Biomarkers for Early Prediction of Outcome After Moderate-to-Severe Traumatic Brain Injury. DEVELOPMENTAL MEDICO-LIFE-SCIENCES, 3(6), 24-31. https://doi.org/10.69750/dmls.03.06.0216
Vancouver
Rahim R, Mushtaq U, Abbas E. Serum Biomarkers for Early Prediction of Outcome After Moderate-to-Severe Traumatic Brain Injury. DEVELOPMENTAL MEDICO-LIFE-SCIENCES. 2026;3(6):24-31. doi:10.69750/dmls.03.06.0216
BibTeX
@article{Rahim2026,
author = {Rahim, Rimmal and Mushtaq, Umama and Abbas, Esha},
title = {Serum Biomarkers for Early Prediction of Outcome After Moderate-to-Severe Traumatic Brain Injury},
journal = {DEVELOPMENTAL MEDICO-LIFE-SCIENCES},
year = {2026},
volume = {3},
number = {6},
pages = {24--31},
doi = {10.69750/dmls.03.06.0216}
}
EUVIMED